Identifier
etd-11092016-164024
Degree
Doctor of Philosophy (PhD)
Department
Veterinary Medical Sciences - Pathobiological Sciences
Document Type
Access to Dissertation Restricted to LSU Campus
Abstract
Herpes simplex virus type-1 (HSV-1) and its closely related type-2 (HSV-2) viruses cause important clinical manifestations in humans including acute ocular disease and genital infections. These viruses establish latency in the trigeminal ganglionic and dorsal root neurons, respectively. Both viruses are widespread among humans and can frequently reactivate from latency causing disease. Currently, there are no vaccines available against herpes simplex viral infections. However, a number of promising vaccine approaches are being explored in pre-clinical investigations with few progressing to early phase clinical trials. Consensus research findings suggest that robust humoral and cellular immune responses may partially control the frequency of reactivation episodes and reduce clinical symptoms. Live-attenuated viral vaccines have long been considered as a viable option for generating robust and protective immune responses against viral pathogens. Varicella zoster virus (VZV) belongs to the same alphaherpesvirus subfamily with herpes simplex viruses. A live-attenuated VZV vaccine has been extensively used in a prophylactic and therapeutic approach to combat primary and recurrent VZV infection indicating that a similar vaccine approach may be feasible for HSVs. In this dissertation, we summarize pre-clinical approaches to HSV vaccine development and current efforts to test certain vaccine approaches in human clinical trials. Also, we discuss the potential advantages of using a safe, live-attenuated HSV-1 vaccine strain to protect against both HSV-1 and HSV-2 infections.
Date
2016
Document Availability at the Time of Submission
Student has submitted appropriate documentation to restrict access to LSU for 365 days after which the document will be released for worldwide access.
Recommended Citation
Stanfield, Brent Allison Damico, "Immunopathogenesis Of Herpes Simpex Viruses: Design And Testing Of Novel Vaccines To Prevent Herpes Viral Infections" (2016). LSU Doctoral Dissertations. 4359.
https://repository.lsu.edu/gradschool_dissertations/4359
Committee Chair
Kousoulas, Konstantin
DOI
10.31390/gradschool_dissertations.4359